| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $140.91M | $179.59M | $141.53M | $247.45M | $124.88M |
| R&D | $92.85M | $115.36M | $103.82M | $112.46M | $73.92M |
| SG&A | $38.55M | $41.73M | $37.70M | $32.99M | $22.62M |
| Operating Income | -$140.91M | -$179.59M | -$141.53M | -$247.45M | -$124.88M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | – | – | – |
| Net Income | -$124.55M | -$161.65M | -$125.04M | -$242.81M | -$122.76M |
| EPS (basic) | -0.4400 | -0.6900 | -0.8300 | -1.9900 | -1.8500 |
| EPS (diluted) | -0.4400 | -0.6900 | -0.8300 | -1.9900 | -1.8500 |
| Shares (diluted) | $283.53M | $233.82M | $150.18M | $122.02M | $66.29M |